The S&P/ASX Small Ordinaries index (ASX: XSO) closed 20.8 points higher at 3,386.0, up 0.62% for yesterday's session, although the index remains down 2.16% over the past five days.
Several companies have delivered fresh operational and corporate milestones across gold, critical minerals, sports technology and autonomous mining solutions this morning. You can read about the following and more throughout the day.
A growing Ebola outbreak in central Africa has reignited investor interest in antiviral biodefence plays, helping lift shares in Island Pharmaceuticals Ltd (ASX:ILA, OTC:ILA) just as the company moves deeper into US government-linked Marburg virus programs.
ILA saw a sharp share price rally on Monday, with the stock surging more than 20% after the World Health Organization (WHO) declared an international public health emergency tied to the outbreak in the Democratic Republic of Congo and Uganda, drawing renewed market attention to Island’s antiviral candidate Galidesivir.
Ion Video Ltd (ASX:IOV) has eliminated all outstanding debt after exercising its right to convert the remaining $2.65 million in convertible notes into fully paid shares.
The conversion, completed at the first available conversion date under the note terms, removes future interest obligations and simplifies the company’s capital structure as it shifts focus to commercialisation.
Aland Equity Group (ASX:AEG) has moved to expand its funds management business into the property sector through a series of long-term property funding agreements tied to projects associated with chairman Alex Brinkmeyer.
The agreements provide AEG with exclusive rights to establish wholesale property funds to finance residential, seniors living, mixed-use and commercial developments across regional New South Wales and areas adjacent to Canberra. The potential pipeline spans more than 4,200 residential lots and more than 100,000 square metres of business park net lettable area.
BCAL Diagnostics Ltd (ASX:BDX) has established national referral pathways for its early cancer detection test portfolio, with clinical referral forms now available through Best Practice and Medical Director, platforms used by about 97% of Australian GPs.
The integration gives BCAL a direct route into primary care workflows, where patient risk assessment and referral decisions are commonly made, supporting broader access to its blood-based cancer detection tests.
Lightning Minerals Ltd (ASX:L1M, FRA:YZ1) has identified tungsten potential at its 100%-owned Warby Project in North Queensland following a review of historical regional drainage sampling data and recent field reconnaissance.
The review highlighted tungsten anomalies of up to 102ppm W from active stream sediment samples, pointing to an additional exploration target beyond the company’s core gold and copper focus.
Atomic Eagle Ltd (ASX:AEU, FRA:6QZ0) has moved to significantly expand its uranium footprint in Zambia, securing an option to acquire the large-scale Sitwe Uranium Project in the country’s northeastern Luangwa Valley as it continues building out a district-scale uranium portfolio in southern Africa.
The ASX-listed explorer said the 429-square-kilometre project would increase its Zambian tenement holdings by about 38% and strengthen its position alongside the company’s flagship Muntanga Uranium Project.
European Lithium Ltd (ASX:EUR, OTCQB:EULIF) has entered a binding Scheme Implementation Deed with NASDAQ-listed Critical Metals Corp for CRML to acquire 100% of EUR’s issued share capital and listed options by way of schemes of arrangement.
Under the proposed all-scrip transaction, EUR shareholders will receive 0.035 new CRML shares, either directly or as ASX-listed CDIs, for each EUR share held. The offer implies A$0.58 per EUR share, representing a 137% premium to EUR’s last uninterrupted closing price and a 113% premium to its 20-day VWAP.
Provaris Energy Ltd (ASX:PV1, OTC:GBBLF, FRA:WS90) has strengthened plans for a compressed hydrogen export supply chain from Norway to Northern Europe after signing a co-operation agreement with Kawasaki Kisen Kaisha Ltd, known as “K” Line, and Norwegian Hydrogen.
Provaris has entered a co-operation agreement with shipping group “K” Line and Norwegian Hydrogen AS to advance a commercial hydrogen shipping solution for the FjordH2 Export Project at Ørskog in Norway.